American Society of Anesthesiologists' (ASA) Physical Status System and Risk of Major Clavien-Dindo Complications After Robot-Assisted Radical Prostatectomy at Hospital Discharge: Analysis of 1143 Consecutive Prostate Cancer Patients.

American Society of Anesthesiologists’ (ASA) Clavien-Dindo grading complications system Physical status system classification Postoperative complications Prostate cancer Radical prostatectomy Robot-assisted radical prostatectomy

Journal

Indian journal of surgical oncology
ISSN: 0975-7651
Titre abrégé: Indian J Surg Oncol
Pays: India
ID NLM: 101532448

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 20 12 2021
accepted: 28 06 2022
entrez: 23 1 2023
pubmed: 24 1 2023
medline: 24 1 2023
Statut: ppublish

Résumé

To test the hypothesis of associations of preoperative physical status system with major postoperative complications at hospital discharge in prostate cancer (PCa) patients treated with robot-assisted radical prostatectomy (RARP). In a period ranging from January 2013 to October 2020, 1143 patients were evaluated. The physical status was assessed by the American Society of Anesthesiologists' (ASA) system, which was computed trained anesthesiologists. The Clavien-Dindo system was used to classify postoperative complications, which were coded as major if greater than 1. ASA physical status system included class I in 102 patients (8.9%), class II in 934 subjects (81.7%), and class III in 107 cases (9.4%). Clavien-Dindo complications were distributed as follows: grade 1: 141 cases (12.3%), grade 2: 108 patients (9.4%), grade 3a: 5 subjects (0.4%), grade 3b: 9 patients (0.8%), and grade 4a: 3 cases (0.3%). Overall, major complications were detected in 125 cases (10.9%). On multivariate analysis, major Clavien-Dindo complications were predicted by ASA score grade II (adjusted odds ratio, OR = 2.538; 95%CI 1.007-6.397; In RARP surgery, the risk of major postoperative Clavien-Dindo complications increased as the physical status system deteriorated independently by performing or not a PLND and/or large intraoperative blood lost. The ASA score system was an effective predictor of major Clavien-Dindo complications, which delayed LOHS in RARP surgery. Confirmatory studies are required. The online version contains supplementary material available at 10.1007/s13193-022-01577-9.

Identifiants

pubmed: 36687253
doi: 10.1007/s13193-022-01577-9
pii: 1577
pmc: PMC9845474
doi:

Types de publication

Journal Article

Langues

eng

Pagination

848-857

Informations de copyright

© The Author(s) 2022.

Déclaration de conflit d'intérêts

Conflict of InterestThe authors declare that they have no conflict of interest.

Références

Urol Oncol. 2018 Apr;36(4):157.e7-157.e13
pubmed: 29273350
J Robot Surg. 2022 Feb;16(1):45-52
pubmed: 33559802
Asian J Urol. 2016 Apr;3(2):88-95
pubmed: 29264170
Urol Int. 2019;103(1):8-18
pubmed: 30731456
Am J Surg Pathol. 2016 Feb;40(2):244-52
pubmed: 26492179
Urol Int. 2016;97(1):32-41
pubmed: 26998904
J Natl Compr Canc Netw. 2019 May 1;17(5):479-505
pubmed: 31085757
J Endourol. 2021 Jun;35(6):922-928
pubmed: 30398382
Minerva Urol Nefrol. 2019 Apr;71(2):136-145
pubmed: 30767495
BJU Int. 2019 Sep;124(3):441-448
pubmed: 30681267
BJU Int. 2018 Nov;122(5):801-807
pubmed: 29727912
Scand J Urol. 2019 Feb;53(1):26-33
pubmed: 30727795
Anaesthesia. 1995 Mar;50(3):195-9
pubmed: 7717481
JAMA. 1961 Oct 21;178:261-6
pubmed: 13887881
Endocr J. 2001 Oct;48(5):573-8
pubmed: 11789562
Minerva Urol Nefrol. 2019 Oct;71(5):516-523
pubmed: 31241272
J Endourol. 2017 Sep;31(9):864-871
pubmed: 28853623
BJU Int. 2021 Mar;127(3):318-325
pubmed: 32869940
Anesthesiology. 2017 Apr;126(4):614-622
pubmed: 28212203
J Robot Surg. 2015 Sep;9(3):249-55
pubmed: 26531206
Anesthesiology. 1978 Oct;49(4):239-43
pubmed: 697077
Eur Urol. 2017 Apr;71(4):618-629
pubmed: 27568654
World J Urol. 2020 Nov;38(11):2799-2809
pubmed: 31980875
Urol Int. 2019;103(1):25-32
pubmed: 31067558
Anesthesiology. 1978 Oct;49(4):233-6
pubmed: 697075
Actas Urol Esp. 2013 Jan;37(1):1-11
pubmed: 22824080
Urology. 2019 Nov;133:135-144
pubmed: 31336110
Minerva Urol Nefrol. 2020 Oct;72(5):595-604
pubmed: 31920063

Auteurs

Antonio Benito Porcaro (AB)

Present Address: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Riccardo Rizzetto (R)

Present Address: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Nelia Amigoni (N)

Present Address: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Alessandro Tafuri (A)

Present Address: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Alberto Bianchi (A)

Present Address: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Sebastian Gallina (S)

Present Address: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Rossella Orlando (R)

Present Address: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Emanuele Serafin (E)

Present Address: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Alessandra Gozzo (A)

Present Address: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Clara Cerrato (C)

Present Address: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Giacomo Di Filippo (G)

Department of General and Hepatobiliary Surgery, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Filippo Migliorini (F)

Present Address: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Stefano Zecchini Antoniolli (SZ)

Present Address: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Giovanni Novella (G)

Present Address: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Vincenzo De Marco (V)

Present Address: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Matteo Brunelli (M)

Department of Pathology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Maria Angela Cerruto (MA)

Present Address: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Enrico Polati (E)

Department of Anesthesiology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Alessandro Antonelli (A)

Present Address: Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Classifications MeSH